O'Dowd Sarah A 4
4 · Protagonist Therapeutics, Inc · Filed May 28, 2021
Insider Transaction Report
Form 4
O'Dowd Sarah A
Director
Transactions
- Award
Stock Option (right to buy)
2021-05-27+18,000→ 18,000 totalExercise: $35.23Exp: 2031-05-26→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest at the earlier of (i) May 27, 2022, or (ii) the date of the 2022 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan).